Inventor · disambiguated record
Jan Brase
Also filed as: BRASE JAN · BRASE JAN CHRISTOPH
1 granted patent·10 pending applications·0 citations·filing 2008–2022
13Inventor score
Files withSIVIDON DIAGNOSTICS GMBH3MYRIAD INT GMBH2NOVARTIS AG2BRASE JAN CHRISTOPH1GEHRMANN MATHIAS1
Top patents by PatentIndex Score
11 records- 0168US2022307090A1Method for predicting the response to chemotherapy in a patient suffering from or at risk of developing recurrent breast cancerMYRIAD INT GMBH·Filed 2022·Application pending·0 cites
- 0263US2019144949A1Method for predicting the response to chemotherapy in a patient suffering from or at risk of developing recurrent breast cancerMYRIAD INT GMBH·Filed 2019·Application pending·0 cites
- 0358US2014228241A1Method for predicting the response to chemotherapy in a patient suffering from or at risk of developing recurrentbreast cancerGEHRMANN MATHIAS·Filed 2012·Application pending·0 cites
- 0452US2017081728A1Method for predicting the response to chemotherapy in a patient suffering from or at risk of developing recurrent breast cancerSIVIDON DIAGNOSTICS GMBH·Filed 2016·Application pending·0 cites
- 0550US2011143946A1Method for predicting the response of a tumor in a patient suffering from or at risk of developing recurrent gynecologic cancer towards a chemotherapeutic agentSIEMENS HEALTHCARE DIAGNOSTICS·Filed 2008·Application pending·0 cites
- 0648US10301685B2Method for predicting the benefit from inclusion of taxane in a chemotherapy regimen in patients with breast cancerSIVIDON DIAGNOSTICS GMBH·Filed 2017·Granted May 28, 2019·0 cites·10 claims
- 0747US2015376714A1Method for predicting the benefit from inclusion of taxane in a chemotherapy regimen in patients with breast cancerSIVIDON DIAGNOSTICS GMBH·Filed 2014·Application pending·0 cites
- 0847US2024310266A1Biomarkers for cancer and methods of use thereofNOVARTIS AG·Filed 2022·Application pending·0 cites
- 0941US2021348238A1Tumor mutation burden alone or in combination with immune markers as biomarkers for predicting response to targeted therapyNOVARTIS AG·Filed 2019·Application pending·0 cites
- 1030US2016348183A1Method for predicting the response and survival from chemotherapy in patients with breast cancerMYRIAD GENETICS INC·Filed 2015·Application pending·0 cites
- 1118US2012264638A1CIRCULATING miRNAs AS NON-INVASIVE MARKERS FOR DIAGNOSIS AND STAGING IN PROSTATE CANCERBRASE JAN CHRISTOPH·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jan Brase files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →